Cargando…
Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China
We aimed to assess the cost-effectiveness of (1) treating acute hepatitis C virus (HCV) vs. deferring treatment until the chronic phase and (2) treating all chronic patients vs. only those with advanced fibrosis; among Chinese genotype 1b treatment-naïve patients who injected drugs (PWID), using a c...
Autores principales: | Liu, Yin, Zhang, Hui, Zhang, Lei, Zou, Xia, Ling, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037788/ https://www.ncbi.nlm.nih.gov/pubmed/32012839 http://dx.doi.org/10.3390/ijerph17030800 |
Ejemplares similares
-
Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic
por: Frankova, Sona, et al.
Publicado: (2023) -
Hepatitis C Reinfection in People Who Inject Drugs in Resource-Limited Countries: A Systematic Review and Analysis
por: Muller, Abbe, et al.
Publicado: (2020) -
Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People Who Inject Drugs in China and Thailand
por: Jackson, J. Brooks, et al.
Publicado: (2014) -
Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China
por: Fang, Kailu, et al.
Publicado: (2023) -
Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries
por: Maticic, Mojca, et al.
Publicado: (2014)